Richard B Lock

18PUBLICATIONS
71CO-AUTHORS
Haematological tumoursMolecular targetsChemotherapyGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 23, 2026
Preclinical evaluation of the ROR1-targeting antibody-drug conjugates zilovertamab vedotin and VLS-211 against B-cell ALL patient-derived xenografts.

|Apr 27, 2026
Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young.

|Mar 18, 2026
Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the young.

Ashleigh M Fordham, Lauren M Brown, Chelsea Mayoh

|Mar 19, 2025
Inhibition of the NLRP3 inflammasome using MCC950 reduces vincristine-induced adverse effects in an acute lymphoblastic leukemia patient-derived xenograft model.

Hana Starobova, Hannah McCalmont, Svetlana Shatunova

|Feb 21, 2025
Immune-deficient MISTRG mice support expansion of leukaemia-initiating cells in xenograft models of paediatric acute myeloid leukaemia.

Patrick Connerty, Jinhan Xie, Fatima El-Najjar

|Jan 23, 2025
Targeting LMO2-induced autocrine FLT3 signaling to overcome chemoresistance in early T-cell precursor acute lymphoblastic leukemia.

Cedric S Tremblay, Jesslyn Saw, Feng Yan

Pageof 3

Frequent Collaborators

6 joint publications

Chelsea Mayoh

3 joint publications

Toby Trahair

3 joint publications

Peter Trebilcock

3 joint publications

Anica Avila